An interventional study of Electrical Impedance Tomography (EIT)-Guided Lung Recruitment in Acute Respiratory Distress Syndrome, sponsored by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. Not yet recruiting at 2 sites in Italy. Open to participants aged 1 Month to 10 Years. Per ClinicalTrials.gov, last updated 2026-02-11.
Sponsored by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 91 studies in Respiratory Distress Syndrome with a site in Italy — 21 open to participants now, 24 under way, 2 of them phase 3. Respiratory Distress Syndrome · Italy.
Among the 91 studies in Respiratory Distress Syndrome with a site in Italy, this one is the 49th largest by planned enrollment of the 49 interventional ones that give a count, is one of 3 that started in 2026, is one of 31 with no phase, reaches primary completion later than 11 of the 23 other live ones, and was the 89th registered.
1,389 studies on the registry are indexed under Respiratory Distress Syndrome; 281 are open to participants now.
Browse Respiratory Distress Syndrome studies →21 of the 91 studies in Respiratory Distress Syndrome with a site in Italy are open now. Recruiting first, the newest first:
Istituto Clinico Humanitas · Sites in Italy
Ages 18+
University of Padova · Sites in Italy
Ages 18+ · Healthy volunteers
University College Dublin · Sites in Italy, Croatia, Czechia and 6 more countries
Ages 0 min–28 days
University of Bologna · Sites in Italy
Ages 18–100
BioAegis Therapeutics Inc. · Sites in Italy, United States, Belgium and 10 more countries
Ages 18+
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 196 Respiratory Distress Syndrome studies recruiting now, 116 (59%) set no upper age limit and 50 (26%) stop at 75 or younger; 52 take children under 18; 9 take healthy volunteers.
This study: 1 Month to 10 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
91 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 11 · Phase 3 11
First in 2002; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 8 is below the median of 60 across 823 interventional studies indexed under Respiratory Distress Syndrome.
Median enrollment 50 across the 49 interventional studies, 110 across the 39 observational. Of the 49 that completed or were terminated, 6 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 91 have an industry lead sponsor. The 10 most frequent:
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico is the lead sponsor of 237 studies on the registry; 81 are open to participants now.
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico has 9 studies filed under Respiratory Distress Syndrome — fewer than ten, so there is no comparison to draw.
11 of the studies in Respiratory Distress Syndrome with a site in Italy that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05624450Phase 3AstraZenecaEfficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen | 2027-11-04 |
| NCT04460859Unity Health TorontoRecruitmEnt Assessed by eleCtRical Impedance Tomography | 2026-12 |
| NCT07402174Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoEIT- Guided Lung Recruitment in pARDS | 2026-12-01 |
| NCT07686315Istituto Clinico HumanitasAdvanced Respiratory Monitoring for Safer Mechanical Ventilation in Patients Without Respiratory Failure | 2026-12-30 |
| NCT04903262University of BolognaUltra-Protective Lung Ventilation With Extracorporeal CO2 Removal for Moderate ARDS | 2026-12-31 |
Add all 11 to your calendar (.ics) → With an account.
Among the 91 studies in Respiratory Distress Syndrome with a site in Italy, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Study Title:
EIT-Guided Lung Recruitment Maneuvers in Pediatric ARDS: Effects on Ventilation Distribution and Respiratory Mechanics
Study Objective:
The primary goal of this clinical trial is to determine whether lung recruitment maneuvers guided by Electrical Impedance Tomography (EIT) result in a more homogeneous ventilation distribution and less injurious ventilation in children with pediatric Acute Respiratory Distress Syndrome (pARDS). The study will assess changes in intrapulmonary gas distribution and respiratory mechanics during recruitment maneuvers using both EIT and partitioned respiratory mechanics.
This is a prospective cohort study involving children diagnosed with pARDS. Eligible participants will be consecutively enrolled over time and will undergo a standardized series of staircase lung recruitment maneuvers under continuous EIT monitoring. The final mechanical ventilation (MV) settings will be individualized and titrated based on the EIT-derived response to recruitment.
Main Research Questions:
How can lung recruitment maneuvers be performed safely in children with pARDS? How can we monitor the physiological effects of recruitment on respiratory mechanics? How does recruitment influence the distribution of ventilation within the lungs?
Eligible participants will undergo a series of staircase lung recruitment maneuvers under continuous EIT monitoring. The final mechanical ventilation (MV) settings will be titrated and individualized based on the EIT-derived response to recruitment.
This is a prospective, single-center, interventional physiological study aiming to assess the effects of EIT-guided lung recruitment maneuvers on ventilation distribution and respiratory mechanics in children with pediatric acute respiratory distress syndrome (pARDS).
A total of 8 mechanically ventilated children diagnosed with moderate-to-severe pARDS will be enrolled within 48 hours from intubation. All patients will undergo a standardized staircase recruitment maneuver under continuous monitoring with Electrical Impedance Tomography (EIT). EIT will be used to assess regional ventilation distribution and guide the titration of PEEP to minimize lung collapse and overdistension. Partitioned respiratory mechanics will be measured through esophageal pressure monitoring to assess changes in lung and chest wall compliance, as well as transpulmonary pressure.
Primary outcome is the change in global inhomogeneity index (GI Index) measured before and after recruitment. Secondary outcomes include center of ventilation (CoV), regional ventilation delay (RVD).
Will also considerd overdistension and collapse percentages, changes in lung/chest wall mechanics.
This pilot study will provide physiological data to inform the design of future randomized trials on EIT-guided mechanical ventilation strategies in pediatric ARDS.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This arm includes all participants undergoing a standardized staircase lung recruitment maneuver under continuous monitoring with Electrical Impedance Tomography (EIT). EIT is used to assess regional ventilation distribution and guide the titration of PEEP. Mechanical ventilation settings are adjusted based on individual EIT-derived responses. Respiratory mechanics, including transpulmonary pressure and compliance partitioning, are also recorded to evaluate physiological effects of recruitment.
Device: Electrical Impedance Tomography (EIT)-Guided Lung Recruitment
Staircase Recruitment Maneuver
Global Inhomogeneity Index (GI)
The Global Inhomogeneity Index (GI) is an EIT-derived quantitative measure of ventilation distribution heterogeneity across the lungs. A lower GI index indicates more homogeneous ventilation. GI will be calculated before and after the EIT-guided recruitment maneuver to assess the effect on regional ventilation distribution.
Time frame: Baseline (pre-intervention/procedure/surgery) Immediately after the intervention/procedure/surgery
Differences in Tidal Impedence
Tidal impedance is a parameter derived from electrical impedance tomography (EIT) that reflects the regional distribution of ventilation during a tidal breath. Changes in electrical impedance measured between end-expiration and end-inspiration are proportional to changes in lung air volume, allowing real-time, bedside assessment of ventilation distribution.
Time frame: Baseline (pre-intervention/procedure/surgery) Immediately after the intervention/procedure/surgery
Centre of Ventilation (CoV)
The centre of ventilation is a quantitative measure that describes the geometric mean location of tidal ventilation within the lung along a predefined axis, most commonly the ventral-dorsal or cranio-caudal axis.
Time frame: Baseline (pre-intervention/procedure/surgery) Immediately after the intervention/procedure/surgery
Changes in Regional Ventilation Delay (RVD) Index
The RVD index quantifies the delay in regional ventilation during tidal breathing, indicating the degree of tidal recruitment or delayed filling. It reflects regional mechanical heterogeneity and is expected to decrease after effective lung recruitment.
Time frame: Baseline (pre-intervention/procedure/surgery) Immediately after the intervention/procedure/surgery
Partitioned Respiratory Mechanics
Chest wall and lung elastance, measured by esophageal pressure monitorin
Time frame: Baseline (pre-intervention/procedure/surgery) Immediately after the intervention/procedure/surgery
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — De-identified individual participant data (IPD), including respiratory mechanics and EIT-derived ventilation metrics, will be made available to qualified researchers upon reasonable request. Data will be shared after publication of the primary results and following approval by the principal investigator and ethics committee.
Supporting information: Study protocol, Statistical analysis plan
Time frame: Beginning 6 months after publication; available for up to 2 years.
Access criteria: Researchers must submit a methodologically sound proposal and obtain approval from the principal investigator. In accordance with institutional policy, a formal Data Transfer Agreement (DTA) approved by the hospital's research foundation will be required before any data can be shared.
Data sharing details ↗ · www.policlinico.mi.it
Start is estimated for Mar 2026; primary completion for Dec 2026, 9 months later.
Of 266 non-industry interventional studies with no phase under Respiratory Distress Syndrome, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 42. This study's planned 9 months is below that.
Counting every sponsor, half of 273 studies reached it within 24 months; a quarter within 12 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Respiratory Distress Syndrome →
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico →